Kisspeptin-10, gonadorelin, triptorelin and oxytocin: hypothalamic-pituitary peptides

Four peptides, one axis

Kisspeptin-10, gonadorelin, triptorelin and oxytocin are reagents that often appear side by side in the laboratory, although their points of action sit in different places. The first two concern the hypothalamic-pituitary-gonadal axis, the pathway that researchers describe as a chain of linked steps: neurons in the hypothalamus release a hormone, the pituitary responds by releasing gonadotropic hormones, and the gonads react by producing sex hormones. Oxytocin is made in the same region of the brain, but its role in research is broader.

Such a comparison makes methodological sense. It allows signals sent at different points of one pathway to be compared, and it shows where the action of one receptor ends and another begins. Below we outline the structure of each peptide and what the literature describes, without drawing conclusions that the data do not support.

Kisspeptin-10: a decapeptide from the kisspeptin family

Kisspeptin-10 is a decapeptide with the sequence Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2. It is the C-terminal fragment of longer kisspeptin forms, which arise from a protein encoded by the KISS1 gene, and its carboxyl end is amidated, as in the natural family of these peptides.

The molecule binds to the GPR54 receptor, also called KISS1R, a G protein-coupled receptor. In vitro studies have described its activation as linked to changes in the activity of GnRH-secreting neurons. In animal models, the influence of this pathway on the hypothalamic-pituitary-gonadal axis has been observed. Because the sequence is short, chromatographic and mass spectrometric analysis is straightforward, and batch identity is easy to confirm. The reagent is available as Kisspeptin-10 lyophilisate.

Gonadorelin: a sequence that matches GnRH

Gonadorelin has the sequence pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 and corresponds to the natural hypothalamic hormone GnRH. It acts as an agonist of the GnRH receptor on the gonadotropic cells of the pituitary. In research models it is described as promoting the release of LH and FSH.

The literature stresses that the pituitary response depends on the character of the signal. Short, pulsatile exposure patterns and continuous stimulation lead to different responses. Continuous presence of an agonist is associated with receptor desensitisation, which is why laboratories study both patterns. This makes gonadorelin a convenient reference point when working on the regulation of hormone release. The reagent: gonadorelin.

Triptorelin: an analogue with D-tryptophan

Triptorelin is a synthetic GnRH analogue. In its molecule, the glycine at position 6 has been replaced by D-tryptophan. According to the literature, this modification increases the peptide’s resistance to enzymatic breakdown and prolongs its interaction with the receptor compared with the natural hormone.

For a researcher this is an important feature: triptorelin and gonadorelin act on the same receptor but differ in the duration and strength of their response. The two compounds are often compared in pituitary cell cultures and in animal models. The analogue is also described in the context of hormone-dependent models in vitro. The reagent is available as triptorelin 2 mg.

Oxytocin: a nonapeptide with a disulphide bridge

Oxytocin is a nonapeptide with the sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2. Two cysteine residues form a disulphide bridge that closes a ring in the middle of the molecule. The peptide is made in the hypothalamus and released from the posterior pituitary.

Oxytocin acts as an agonist of the oxytocin receptor, a member of the G protein-coupled receptor family. After activation, a phospholipase C-dependent pathway is triggered, which leads to a rise in intracellular calcium. Studies have also described affinity for vasopressin receptors, particularly at higher concentrations, so selectivity is worth checking in every project.

In isolated tissue preparations, contraction of uterine smooth muscle has been described. In animal models, the effect of the peptide on social behaviour and on nervous system signalling has been studied. The reagent is available as oxytocin in 2, 5 and 10 mg quantities.

Comparison at a glance

Peptide	Length	Receptor described in research	Format
Kisspeptin-10	10 residues	GPR54 (KISS1R)	lyophilisate 5 and 10 mg
Gonadorelin	10 residues	GnRH receptor	lyophilisate 2 and 5 mg
Triptorelin	10 residues	GnRH receptor	lyophilisate 2 mg
Oxytocin	9 residues	oxytocin receptor	lyophilisate 2, 5 and 10 mg

The table shows that the first three peptides are decapeptides, and two of them act on the same GnRH receptor. Oxytocin is shorter and acts on a separate receptor, which makes it a useful reference in comparative projects alongside the hypothalamic-pituitary axis.

How to plan an experiment

First decide which point of the axis you want to study. If you are interested in entering the GnRH pathway, kisspeptin-10 or gonadorelin is the natural choice. If you are comparing the response to an analogue with prolonged action, set gonadorelin against triptorelin under the same conditions. Add oxytocin when the project covers G protein-coupled receptors outside the gonadal axis.

Also plan for selectivity. Because some receptors show affinity for more than one ligand, include a negative control and check whether the observed effect depends on the receptor you have chosen. Record the batch number, the date the solution was prepared and the concentration, as this makes later reproduction of results much easier.

What to measure in the results

With four peptides acting on different receptors, each readout should answer a specific question. In pituitary systems, LH and FSH secretion after exposure to a GnRH agonist, that is gonadorelin or triptorelin, is usually measured. In cell cultures for kisspeptin and oxytocin, a common readout is intracellular signalling, for example changes in calcium concentration after activation of a G protein-coupled receptor.

A well-designed set also includes a time point. Because the response depends on the exposure pattern, record the intervals at which the peptide was added and how long its concentration was maintained. This makes it easier to compare series and to explain differences between batches.

Results from animal models and from in vitro studies do not transfer directly to other systems. For this reason, the project description should clearly state the model, the cell type and the conditions under which the data were obtained. This discipline matters as much as the choice of reagent.

Why order these reagents from MOLEVIA

Every batch of each of these peptides has a purity of at least 99%, confirmed by HPLC, and a mass confirmed by MS. The products are supplied as lyophilisate in vials. Orders are dispatched within 24 hours. In Poland the parcel is delivered to an InPost parcel locker, and across Europe it is delivered by the DPD courier. The reagents are for research use only (RUO). Full details of delivery and order handling are on our delivery page.

Working in the laboratory

Store the lyophilisate of all four peptides at -20 °C, tightly closed and protected from moisture and light. Before opening a vial, let it reach room temperature to limit water condensing on the powder.

Carry out reconstitution according to your research protocol, usually in water intended for analysis or in bacteriostatic water. After dissolving, keep the solution at 2-8 °C and divide it into working aliquots to avoid repeated freezing and thawing. Calculate the working concentration with the concentration calculator before you start work with samples.